Heinerman J. Fascinating Colostrum: An Ancient Food for Modern Times, 1998.
Borissenko M. Malaysia Colostrum Piglet Clinical Trial. *Unpublished Research. October 1998.
Conclusion: Increased intestinal surface area resulted in improved nutritional absorption. Piglets grew faster and healthier (increased lean muscle mass, less fat}, thereby eliminating the need for farmers to use antibiotics .
* Research sponsored by Symbiotics CEO and founder Douglas Wyatt
Playford RJ, Floyd DN, Macdonald CE, Calnan DP, Adenekan RO, Johnson W, Goodlad RA, Marchbank T. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut. 1999;44:653-658.
Conclusion: Bovine colostrum could provide a novel, inexpensive approach for the prevention and treatment of the injurious effects of NSAIDs on the gut and may also be of value for the treatment of other ulcerative conditions of the bowel.
Playford RJ, MacDonald CE, Calnan DP, Floyd DN, Podas T, Johnson W, Wicks AC, Bashir 0, March bank T. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug induced increase in intestinal permeability. Clinical Science (London). 2001 Jun;100(6):627-33.
Conclusion: These studies provide preliminary evidence that bovine colostrum, which is already currently available as an over-the-counter preparation, may provide a novel approach to the prevention of NSAID-induced gastrointestinal damage in humans.
Cesarone MR, Belcaro G, Di Renzo A, Dugall M, Cacchio M, Ruffini I, Pellegrini L, Del Boccio G, Fano F, Ledda A, Bottari A, Ricci A, Stuard S, Vinciguerra G. Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino. Clin Appl Thromb Hemost. 2007 Apr;13(2):130-6.
Conclusion: Colostrum, both in healthy subjects and high-risk cardiovascular patients, is at least 3 times more effective than vaccination to prevent flu and is very cost-effective .
Belcaro G, Cesarone MR, Cornelli U, Pellegini L, Ledda A, Grossi MG, Dugall M, Ruffini I, Fano F, Ricci A, Stuard S, Luzzi R, Grossi MG, Hosoi M. Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. Panminerva Med. 2010 Dec;52(4):269-75.
Conclusion: Individuals receiving either colostrum plus probiotics or colostrum plus probiotics plus vaccination fared better than those receiving vaccination alone or no treatment at all. They experienced fewer incidences of flu and fewer flu days. Those receiving a vaccination had twice as many episodes of flu than those receiving the colostrum and probiotic supplement.
Keech A, Nwabuko U, Chikezie C, Wogu GUE. Peptide immunotherapy: a new direction in HIV/AIDS treatment. Advanced Protein Systems, Unpublished Research. February 2000.
Conclusion: HIV/AIDS studies suggest that even in the "worst of the worst" viral infections, PRPs could return the human immune system to normal functioning, such that it is able to successfully fight off viral invaders. The ability of PRPs to stimulate an otherwise insufficient immune response by inducing the production of new helper T-cells appears to enable an HIV/AIDS patient's immune system to recover sufficiently so that it can fight HIV on its own .
*Research sponsored by Douglas Wyatt using Colostrum-LD® and Viralox PRP Spray.
Buckley JD, Abbott MJ, Brinkworth GD, Whyte PB. Bovine colostrum supplementation during endurance running training improves recovery, but not performance. J Sci Med Sport. 2002 Jun;5(2):65-79.
Conclusion: Supplementation with bovine colostrum (60g/d) did not increase plasma IGF-1 levels or improve performance during an initial bout of incremental running to exhaustion. Performance during a second bout of exercise may be improved possible due to an enhancement of recovery.
Antonio J, Sanders MS, Van Gammeren D. The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women. Nutrition. 2001;17:243-247.
Conclusion: Supplementation with bovine colostrum (20 g/d) in combination with exercise training for 8 weeks may increase bone-free lean body mass in active men and women. This study showed that a dose of 60 g/d in previous studies was not necessary and was attributed to advances in bovine colostrum processing (Liposomal Delivery).
*Research sponsored by Douglas Wyatt using Colostrum-LD®.
Marchbank T, Davidson G, Oakes JR, Ghatei MA, Patterson M, Moyer MP, Playford RJ. The nutraceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes. AM J Physiol Gastrointest Liver Physiol. 2001 Mar;300(3):G477-84.
Conclusion: In a physiologically relevant sports model, colostrum appears beneficial in maintaining gut stability. Mechanisms may include reduced apoptosis and paracellular permeability.
PATENT: Stimulating cell growth (4,440,860 – April 3, 1984)
Compositions and methods for promoting cell growth featuring, in one aspect, cell culture media containing milk or colostrum and fibronectin; fibronectin is preferably pre-coated onto the culture substrate.
Assignee: The Children’s Medical Center Corporation
Country: Boston, MA
Filed: March 2, 1981
BACKGROUND OF THE INVENTION:
This application is a continuation-in-part of Klagsbrun, “Stimulating Cell Growth,” Ser. No. 113,229, filed Jan. 18, 1980, which in turn is a continuation-in-part of Klagsbrun, “Simulating Cell Growth,” Ser. No. 953,491, filed Oct. 23, 1978 both now abandoned.
PATENT: Colostrum fraction, a process of preparing it and its uses as a supplement in cell culture media (5,500,229 – March 19, 1996)
The invention discloses a colostrum fraction having a low endotoxin, protein and immunoglobulin concentration. The colostrum fraction is prepared by ultrafiltration of defatted colostrum pretreated in a desired manner by using a membrane having a molecular cut off of 100,000 daltons. The invention also discloses the use of the colostrum fraction as a supplement in cell culture media.
Inventor: Aalto, et al.
Assignee: Viable Bioproducts, Ltd.
Filed: December 15, 1993
BACKGROUND OF THE INVENTION:
This application is a continuation of application Ser. No. 07/792,818, filed Nov. 15, 1991, now abandoned.
Kshirsagar AY, Vekariya MA, Gupta V, Pednekar AS, Mahna A, Patankar R, Shaikh A, Nagur B. A comparative study of colostrum dressing versus conventional dressing in deep wounds. Journal of Clinical and Diagnostic Research. 2015 Apr;9(4):PC01-4.
Conclusion: Colostrum powder dressings are safe promoters of wound healing with more patient compliance in terms of less pain, less number of dressing required. This treatment though found to be more expensive than conventional dressings; results indicate that colostrum powder dressings may be used as an adjunct in management of deep wound.
*Research study used Colostrum-LD®.